02 March 1998
Effect of streptokinase on platelet function, glycoproteins and membrane structure in patients with an acute myocardial infarction: ex vivo and in vitro studies
Maria Kicińska, Jacek GórskiMed Sci Monit 1998; 4(2): BR215-221 :: ID: 502541
Abstract
The current study was designed to elucidate mechanisms responsible for alterations of platelet activation and aggregation in patients with an acute myocardial infarction (AMI) treated with streptokinase (SK). Platelet function and membrane structure were examined prior to and one hour after i. v. administration of SK in 26 patients with an AMI. In 10 patients with a myocardial infarction, not undergoing thrombolytic therapy, in vitro platelet membrane glycoproteins (GP) were examined in platelet rich plasma following incubation with SK. ADP, adrenaline, collagen and ristocetin induced platelet aggregation were studied by Born's method, b-thromboglobulin (bTG) and platelet factor 4 (PF4) concentrations in plasma were determined using ELISA, von Willebrand's factor was determined by agglutination, GP Ib and GP IIb/IIIa by indirect immunofluorescence using appropriate monoclonal antibodies, and the platelet membrane structure by electronic paramagnetic resonance using spin labels. The results obtained confirm that in patients with an AMI treated with SK, platelet function is altered: platelet activation is enhanced, which is manifested by an increase in bTG and PF4 concentrations, and at the same time their aggregation is disturbed. In addition, SK was shown to induce structural changes in protein conformation and in the fluidity of platelet membrane lipids which may be responsible for the alterations in platelet aggregation. Additional reasons for platelet aggregation disturbances may be due to the decrease in platelet GB Ib and IIb/IIIa, as well as a considerable drop in the fibrinogen concentration observed following SK therapy.
Keywords: Streptokinase, Platelet Aggregation, betathromboglobulin, platelet factor 4, platelet glycoproteins, platelet membrane structure
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952